Cost-Minimization Analysis in Postoperative Pain Management After Non-Cardiac Major Surgeries in China: Parecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs and Tramadol
Barra, M, Remak, E, Liu, D, Xie, L, Abraham, L, Sadosky, A, Kongnakorn, T
Published in Value in health (01.11.2016)
Published in Value in health (01.11.2016)
Get full text
Journal Article
Budget Impact Analysis of Botulinum Toxin a Therapy for Upper Limb Spasticity in the United Kingdom
Kurth, H, Remak, E, Hortobagyl, L, Desai, K, Abogunrin, S, Dinet, J, Gabriel, S, Bakheit, A.M
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
EE243 Cost-Effectiveness Model Conceptualisation in Fibrodysplasia Ossificans Progressiva
Cheung, AM, Remak, E, Evans, R, Xin, Q, Boing, E, Pignolo, RJ
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
PCN78 CHANGES IN HEALTH STATE COSTS IN HEPATOCELLULAR CARCINOMA (HCC)
Muszbek, N., Evans, R., Remak, E., Brennan, V., Colaone, F., Shergill, S.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCN98 COST-COMPARISON ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) AND TRANSARTERIAL CHEMOEMBOLISATION (TACE) IN UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Muszbek, N., Evans, R., Remak, E., Brennan, V., Colaone, F., Shergill, S.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PCN414 INCLUSION OF SUBSEQUENT TREATMENTS WITH CURATIVE INTENT IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC) PARTITIONED SURVIVAL MODELS
Muszbek, N., Remak, E., Evans, R., Brennan, V., Colaone, F., Shergill, S., Hawkins, N., Abrams, K.R.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article